Mirtazapine Tablet, Film Coated
Product Images NDC 0904-6519

2 FDA label images from Major Pharmaceuticals · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Mirtazapine (NDC 0904-6519). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Major Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure diagram of the active ingredient Mirtazapine, showing its molecular framework with rings and bonds characteristic of its chemical composition.*
FDA Label Image

15mg Carton Label (F8ae854c Da1b 8d9e 6729 F95af974d965 00)

15mg Carton Label (F8ae854c Da1b 8d9e 6729 F95af974d965 00)
Mirtazapine 15 mg film-coated tablets label by Major Pharmaceuticals. The Unit Dose packaging contains 100 tablets (10 x 10) with prescription-only status. The label includes the NDC 0904-6519-61, pharmacist dispensing instructions, storage conditions, and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.